knowledge -WSS

knowledge

author：Wikipedia 2025-09-29 13:46:06 - browse：48

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

These days, the surefire way to get ahead in health insurance is to become a health care provider, and Elevance just upped the ante. It’s joining with private equity to launch a $4 billion primary care company.

Elevance leaders divulged more about the company’s venture with Clayton, Dubilier & Rice on its first quarter earnings call Thursday. The partners announced the new company, yet unnamed, earlier this week, but the release was light on detail. The strategic partnership will house Elevance and CD&R’s doctors, clinics, and the technologies that help those doctors manage their patients.

Health insurers specialize in managing medical costs, and through ventures like this, they apply that expertise to managing patients’ chronic medical conditions. In arrangements like Medicare Advantage, where insurers are paid set amounts for members’ care, they’re incentivized to keep those patients healthy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： 15 die by electrocution after transformer explodes in northern India

hotspot

WSS

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

STAT Virtual Event: JPM Recap, Live!

Twill hunts for pharma partner to market its depression app

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

explore

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

focus

BioMarin wins approval for gene therapy to treat hemophilia A

STAT Virtual Event: JPM Recap, Live!

Anesthesiologist group: stop taking Ozempic before surgery

15 die by electrocution after transformer explodes in northern India

Virginia high school admissions case could be legal follow

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

BioMarin wins approval for gene therapy to treat hemophilia A

Medicare Advantage coverage denials need scrutiny, senators say

As demand for Covid shots wanes, Moderna seeks its next success

Gene therapy denied for Afghan refugee whose father aided U.S.

explore

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

A Theranos scientist

Male doctors called my cancer incurable. A female doctor showed it wasn't

Profiling embryos to choose those with higher IQs is almost a reality

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

hotspot

hotspot

focus

explore